12,372 trials
Chronic Rhinosinusitis
Primary: Change From Baseline in Symptoms as Measured by a Composite Score for Each Symptom of Nasal Congestion, Facial Pain or Pressure Sensation, and Nasal Discharge (Anterior…
Human Immunodeficiency Virus Type 1 (HIV-1)
Primary: Concentration at End of Dosing Interval (Ctau) of CAB LA Following Administration of CAB LA + RPV LA Q8W — 1.67; 1.61; 1.81 Micrograms per milliliter
Jet Lag Type Insomnia
Primary: Total Sleep Time in the First Two Thirds of the Night — 156.1; 216.4 Minutes — p=<.0001
Metastatic Colorectal Cancer · Metastatic Colon Cancer
Primary: Overall Survival (OS) — 7.4; 4.8 months — p=< .001
Glaucoma, Open-Angle · Ocular Hypertension
Primary: Change From Baseline in Diurnal IOP (as Measured at 8AM and 10AM) Through 3 Months Postoperative — -8.40; -8.48; -7.69; -8.35 mmHg
Cutaneous Common Warts
Primary: The Difference in the Proportion of Subjects With Complete Clearance of All Treated Warts Between the Active and Vehicle at Week 18/End of Post-treatment Efficacy…
Diabetes Mellitus, Type 2
Primary: Change From Baseline in Glycosylated Haemoglobin (HbA1c) — -1.1; -1.5; -1.6; -0.2 Percentage of HbA1c — p=<0.0001
Cutaneous Common Warts
Primary: Difference in the Proportion of Subjects With Complete Clearance of All Treated Warts Between the Active and Vehicle at Week 18/End of Post-treatment Efficacy…
Substance-Related Disorders · Substance Use Disorders · Substance Abuse, Intravenous
Primary: Opioid Craving Using Visual Analogue Scale — 3.909; 6; 4.556; 5.5 score on a scale
Lung Diseases, Interstitial
Primary: Number of Participants With Any Adverse Events — 417 Participants
Crohn Disease
Primary: Percentage of Participants With Clinical Response at Week 16 — 49.1; 37.4 Percentage of participants — p=0.089
Influenza, Human Prevention · Respiratory Syncytial Viruses Prevention
Primary: Geometric Mean Titers (GMTs) of Hemagglutination Inhibition (HI) Antibodies Against Each of the Four Influenza Vaccine Strains as Measured by HI Assay — 178; 179; 111…
Agitation in Patients With Dementia of the Alzheimer's Type · Alzheimer Disease · Agitation,Psychomotor
Primary: Change in CMAI Total Score — -15.4; -10.0; -11.5 score on a scale — p=0.010
Cognitive Dysfunction · Memory Impairment
Primary: Hopkins Verbal Learning Test-Revised (HVLT-R) - Total — 24.4; 24.5; 26.0; 26.5 score on a scale of 0-36 — p=0.32
Kidney Transplant · Hepatitis C · HCV
Primary: Proportion of Patients With Undetectable Hepatitis C Virus (HCV) Polymerase Chain Reaction (PCR) at 12 Weeks After Completion of HCV Treatment — 28 Participants